RYGB progressively increases avidity for a low-energy, artificially sweetened diet in female rats.

Appetite

Institute of Veterinary Physiology, University of Zürich, 8057 Zürich, Switzerland; Zürich Center for Integrative Human Physiology, University of Zürich, 8057 Zürich, Switzerland. Electronic address:

Published: March 2016

Weight re-gain within 2 y after Roux-en-Y gastric bypass (RYGB) is significantly associated with increased intake of and cravings for sweet foods. Here we describe a novel model of this late increase in sweet appetite. Ovariectomized RYGB and Sham-operated rats, with or without estradiol treatment, were maintained on Ensure liquid diet and offered a low-energy, artificially sweetened diet (ASD) 2 h/d. First, we tested rats more than six months after RYGB. ASD meals were larger in RYGB than Sham rats, whereas Ensure meals were smaller. General physical activity increased during ASD meals in RYGB rats, but not during Ensure meals. Second, new rats were adapted to ASD before surgery, and were then offered ASD again during 4-10 wk following surgery. Estradiol-treated RYGB rats lost the most weight and progressively increased ASD intake to >20 g/2 h in wk 9-10 vs. ∼3 g/2 h in Sham rats. Finally, the same rats were then treated with leptin or saline for 8 d. Leptin did not affect body weight, Ensure intake, or activity during meals, but slightly reduced ASD intake in estradiol-treated RYGB rats. Food-anticipatory activity was increased in estradiol-treated RYGB rats during the saline-injection tests. Because increased meal-related physical activity together with larger meals is evidence of hunger in rats, these data suggest that (1) RYGB can increase hunger for a low-energy sweet food in rats and (2) low leptin levels contribute to this hunger, but are not its only cause. This provides a unique rat model for the increased avidity for sweets that is significantly associated with weight recidivism late after RYGB.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728070PMC
http://dx.doi.org/10.1016/j.appet.2015.11.029DOI Listing

Publication Analysis

Top Keywords

rygb rats
16
rats
13
estradiol-treated rygb
12
rygb
11
low-energy artificially
8
artificially sweetened
8
sweetened diet
8
asd meals
8
sham rats
8
rats ensure
8

Similar Publications

Increased COX6A2 promotes pancreatic β-cell apoptosis and is suppressed in diabetic GK rats after Roux-en-Y gastric bypass.

Diabetes

November 2024

Shenzhen University Diabetes Institute, Shenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis, School of Medicine, Shenzhen University, Shenzhen 518060, China.

Roux-en-Y gastric bypass (RYGB) has been shown to inhibit β-cell apoptosis, but the underlying mechanisms are not yet fully understood. Cytochrome c oxidase subunit 6A2 (COX6A2) is expressed in β-cells. Here, we sought to investigate the role of COX6A2 in β-cell apoptosis, especially following RYGB.

View Article and Find Full Text PDF

Wingless-type inducible signaling pathway protein-1 (WISP1) is a newly recognized adipokine, associated with obesity and type 2 diabetes (T2DM). This study aimed to investigate the effect of metabolic and bariatric surgery (MBS) on WISP1 circulating (serum) levels and tissue expression using rat models. We initially investigated whether WISP1 circulating levels were altered between the T2DM and normal rats.

View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates how three types of bariatric surgeries—Roux-en-Y gastric bypass, biliopancreatic diversion with duodenal switch, and single anastomosis duodeno-ileal bypass—affect bile acid levels in male Wistar rats on different diets.
  • Results show that these surgeries increase plasma levels of secondary bile acids, which are associated with reduced body weight and fat gain and improved glucose metabolism.
  • Additionally, the findings highlight connections between bile acids and beneficial gut bacteria as well as short-chain fatty acids, suggesting these surgeries contribute to better metabolic health through these biochemical changes.
View Article and Find Full Text PDF

Roux-en-Y Gastric Bypass may be associated with an alteration of protein bioavailability in relation to intestinal remodeling. Our study aimed to test this hypothesis by Roux-en-Y Gastric Bypass. Diet-induced obese rats underwent Roux-en-Y Gastric Bypass surgery (RYGB rats) while a Sham-operated control group was used.

View Article and Find Full Text PDF

Weight loss in adult male Wistar rats by Roux-en-Y gastric bypass is primarily explained by caloric intake reduction and presurgery body weight.

Am J Physiol Regul Integr Comp Physiol

June 2024

Department of Behavioral Neuroscience, Groningen Institute for Evolutionary Life Sciences (GELIFES), University of Groningen, Groningen, The Netherlands.

Article Synopsis
  • The study investigated how different diets (low-fat vs. high-fat/sucrose) affected weight loss after Roux-en-Y gastric bypass (RYGB) surgery in rats.
  • Rats fed a high-fat/sucrose diet lost more weight post-surgery compared to those on a low-fat diet, primarily due to lower energy intake and initial body weight differences.
  • Interestingly, continuing the high-fat/sucrose diet did not hinder recovery from surgery, even though low-fat dieting led to signs of malaise following RYGB.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!